The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2019

Filed:

Jun. 30, 2015
Applicant:

University of Seoul Industry Cooperation Foundation, Seoul, KR;

Inventors:

Jong-Bum Lee, Seoul, KR;

Yong-Kuk Park, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/64 (2006.01); C12P 19/34 (2006.01); C12Q 1/6844 (2018.01); C12Q 1/6853 (2018.01); C12Q 1/6867 (2018.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C12P 19/34 (2013.01); C12Q 1/6844 (2013.01); C12Q 1/6853 (2013.01); C12Q 1/6867 (2013.01); C12N 2310/14 (2013.01); C12N 2310/16 (2013.01); C12N 2310/532 (2013.01); C12N 2320/32 (2013.01);
Abstract

Disclosed are particles which are introduced into target cells and suppress the expression of specific genes, and a method of manufacturing such particles. More particularly, the present invention relates to DNA-RNA hybrid particles that comprise a DNA strand and an RNA strand that binds to the DNA strand through partial complementary base pairing, in which the DNA strand comprises an aptamer sequence that is able to bind to a target protein produced in a target cell, and the RNA strand comprises an siRNA sequence that binds to a target RNA in the target cell to suppress protein expression from the target RNA. Such hybrid particles are capable of effectively delivering an siRNA therapeutic agent into target cells for the treatment of disease, and have resistance against digestion by in vivo nucleases, DNase and RNase, owing to complementary binding formed between DNA and RNA strands. Also, the present invention relates to a method of manufacturing such DNA-RNA hybrid particles.


Find Patent Forward Citations

Lee, Jong-Bum. (2019). Dna-rna hybrid particles and manufacturing method thereof (U.S. Patent No. 10253317). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10253317

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…